Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 Mar;43(3):305–311. doi: 10.1038/bjc.1981.48

The presence of a tumour in F1 mice partially inhibits the GvH reaction following injection of parental spleen cells.

T Whitmarsh-Everiss, M O Symes
PMCID: PMC2010595  PMID: 7225282

Abstract

(A x CBA(T6)F1 mice bearing F1 mammary carcinomas for 9 days were injected i.v. with A strain spleen cells. The A spleen cells were from either non-immune donors or mice which had received an i.p. injection of F1 tumours cells 9 days previously, and were thus immune to the CBA component of the tumour. Fourteen days after receiving parental spleen cells, the F1-tumour-bearing mice were killed and their spleen ratios and indices were determined as an index of the severity of the graft-versus-host reaction (GvHR) induced. The spleen indices were compared with those in non-tumour-bearing F1 mice, receiving aliquots of the same parental cell suspensions. At the higher doses of A spleen cells, the presence of an F1 tumour reduced the GvHR. At the same time, in 3/5 experiments, the weight of the F1 tumour in mice injected with immune A spleen cells was less than that in F1 mice receiving the same number of tumour cells but no spleen cells. A reduction in GvHR and a decrease in tumour weight was not seen when F1 mice carrying an A strain tumour were injected with A strain spleen cells immune to an F1 tumour. Adding 23-day F1 tumour-bearing F1 spleen cells to A spleen cells did not reduce the GvHR induced in further non-tumour-bearing F1 recipients by the parental cells. This was evidence against the presence of suppressor cells in the tumour-bearing F1 spleen. When 51Cr-labelled A strain spleen cells were injected into F1 mice, some of which had a tumour and therefore an enlarged spleen, there was an inverse relation between the size of the spleen and the number of parental cells therein, per g spleen 4 h after injection. It is thus suggested that the reduction in GvHR in F1-tumour-bearing F1 mice, after injection of parental spleen cells, is due first to a reduction in the concentration of donor cells in the recipient spleen (i.e. the same number of donor cells in a larger spleen) and second to pre-occupation of the donor cells in reacting to the tumour.

Full text

PDF
305

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boyle W. An extension of the 51Cr-release assay for the estimation of mouse cytotoxins. Transplantation. 1968 Sep;6(6):761–764. doi: 10.1097/00007890-196809000-00002. [DOI] [PubMed] [Google Scholar]
  2. FOX M. Cytological estimation of proliferating donor cells during graft-versus-host disease in F1 hybrid mice injected with parental spleen cells. Immunology. 1962 Jul;5:489–495. [PMC free article] [PubMed] [Google Scholar]
  3. Fujimoto S., Greene M. I., Sehon A. H. Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts. J Immunol. 1976 Mar;116(3):791–799. [PubMed] [Google Scholar]
  4. HOWARD J. Changes in the activity of the reticulo-endothelial system (RES) following the injection of parental spleen cells into F1 hybrid mice. Br J Exp Pathol. 1961 Feb;42:72–82. [PMC free article] [PubMed] [Google Scholar]
  5. Milas L., Hunter N., Mason K., Withers H. R. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes. Cancer Res. 1974 Jan;34(1):61–71. [PubMed] [Google Scholar]
  6. Osborne D. P., Jr, Katz D. H. The allogeneic effect on tumor growth. I. Inhibition of a murine plasmacytoma, MOPC 315, by the graft-vs-host reaction. J Immunol. 1977 Apr;118(4):1441–1448. [PubMed] [Google Scholar]
  7. Rees J. A., Symes M. O. Further observations on whether host immunodepression is associated with tumour growth in mice. Br J Cancer. 1971 Sep;25(3):501–504. doi: 10.1038/bjc.1971.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Rumma J., Davies D. J., Cauchi M. N. Effects of graft-versus-host reaction on inhibition of tumor growth in vivo and on tumor cytotoxicity in vitro. Cancer Res. 1977 May;37(5):1389–1394. [PubMed] [Google Scholar]
  9. WIGZELL H. Immunological depression of tumor growth in F1 hybrid/parental strain systems. Cancer Res. 1961 Apr;21:365–370. [PubMed] [Google Scholar]
  10. WOODRUFF M. F., BOAK J. L. INHIBITORY EFFECT OF PRE-IMMUNIZED CBA SPLEEN CELLS ON TRANSPLANTS OF A-STRAIN MOUSE MAMMARY CARCINOMA IN (CBA X A) F1 HYBRID RECIPIENTS. Br J Cancer. 1965 Jun;19:411–417. doi: 10.1038/bjc.1965.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. WOODRUFF M. F., SYMES M. O. The significance of splenomegaly in tumour-bearing mice. Br J Cancer. 1962 Mar;16:120–130. doi: 10.1038/bjc.1962.12. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES